As abnormalities in vascular NO production and transport results in EC dysfunction, leading to various cardiovascular pathologies [80], it will be interesting to evaluate the role of MAGI1, a modulator of NO, in cardiovascular diseases such as hypertension, other angiogenesis-associated disorders or in diabetes, where perturbed expression of NO was reported. Here, MAGI1 is linked to cardiovascular disorder.